Recent Articles

• 
  Celltrion

  US Biosimilar Rule Easing Seen Boosting Celltrion

  Celltrion announced on the 13th that it will immediately reflect global regulators’ relaxed policies on biosimilar development in its ongoing pipeline, aiming to reduce development costs and shorten timelines.The U.S. Food and Drug Administration (FDA) recently released the fourth revised draft of i

  2026.03.13
• 
  AI Healthcare

  Daewoong Pharma: MobiCare Wearable ECG Enables Early AF Detection

  Medical staff at the Gyeongnam branch of the Korea Association of Health Promotion apply the wearable electrocardiogram device “mobiCARE” to a patient. Daewoong Pharmaceutical Daewoong Pharmaceutical announced on the 12th that its wearable electrocardiogram (ECG) testing solution “mobiCARE” has succ

  2026.03.12
• 
  Biopharma

  Alteogen Wins US Patent for Keytruda, Qurex Formulation

  Alteogen headquarters and research center Bioplatform company Alteogen announced on the 12th that it has registered with the United States Patent and Trademark Office (USPTO) a composition patent related to the subcutaneous formulation of Keytruda that combines its Hybrozyme platform-based ALT-B4 (i

  2026.03.12
• 
  Global Expansion

  Korean United Pharma Expands in Mongolia With Cancer Drugs

  Korea United Pharm is accelerating efforts to expand its market share in Mongolia by broadening contact points with local partners. The company announced on the 12th that it had invited GanEm Pharma, a Mongolian distribution company, on the 9th to discuss business strategies for boosting exports. Th

  2026.03.12
• 
  Medical / Research

  Kimchi Probiotics Help Expel Gut Microplastics

  Newsis Experimental results have shown that lactic acid bacteria derived from kimchi may promote the excretion of microplastics from the body. On the 11th, the research team of Dr. Lee Se-hee and Dr. Won Tae-woong at the World Institute of Kimchi announced that they had confirmed that the lactic aci

  2026.03.11
• 
  Biopharma

  Pharmainnovation, Caerance, Daoncare Sign Natural Product MOU

  Photo courtesy of Pharmainnovation Pharmaceutical OTM specialist Pharmainnovation Co., Ltd. announced that it has signed a memorandum of understanding (MOU) for cooperation in the development and commercialization of natural-substance-based products with healthcare platform specialist Carelance Co.,

  2026.03.11
• 
  Medical / Research

  IBS Team Uncovers Neuron-Astrocyte Mechanism in Brain Development

  The Institute for Basic Science (IBS) announced on the 10th that a research team led by Chang-Jin Lee, Director of the Center for Cognition and Sociality, and Research Fellow Sung-Ho Hong has identified the mechanism by which star-shaped non-neuronal cells called astrocytes enable complex and precis

  2026.03.11
• 
  Medical / Research

  10g Albumin Drop Raises Death Risk 137%

  Sarcopenia is a major cause of falls and fractures in old age. This is why the management of albumin, which stores and transports amino acids that serve as raw materials for muscle production, is considered an important condition for health in later life. Getty Images Bank Albumin is often regarded

  2026.03.11
• 
  Biotech

  Seasonal Shifts Worsen Atopic Dermatitis, Skin Barrier Key

  During seasonal transitions, the skin dries out easily and becomes sensitive. This period is particularly prone to symptom aggravation for patients with atopic dermatitis. Getty Images Bank During seasonal transitions, sharp changes in temperature and humidity cause the skin to dry out easily and be

  2026.03.11
• 
  Global Expansion

  Samsung Biologics, Eli Lilly to Build Songdo Biotech Hub

  Samsung Biologics is partnering with Eli Lilly of the United States to establish a domestic base for a world-class open innovation program in Korea.Samsung Biologics announced on the 10th that it has signed an open innovation partnership with Eli Lilly to foster promising Korean biotech companies.Un

  2026.03.11